K
Kangaroo Biomedical develops cell engineering solutions to address unmet needs in reproductive health, focusing on infertility and menopause. Their lead program, Fertilo, utilizes iPSC-derived technology to improve outcomes in IVF and egg freezing procedures. The company is also developing cell therapies aimed at mitigating the effects of menopause.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Kangaroo Biomedical develops cell engineering solutions to address unmet needs in reproductive health, focusing on infertility and menopause. Their lead program, Fertilo, utilizes iPSC-derived technology to improve outcomes in IVF and egg freezing procedures. The company is also developing cell therapies aimed at mitigating the effects of menopause.